Abstract
Although obesity is a global epidemic, the physiological mechanisms involved are not well understood. Recent advances reveal that susceptibility to obesity can be programmed by maternal and neonatal nutrition. Specifically, a maternal low-protein diet during pregnancy causes decreased intrauterine growth, rapid postnatal catch-up growth and an increased risk for diet-induced obesity. Given that the synthesis of the neurotransmitter 5-hydroxytryptamine (5-HT) is nutritionally regulated and 5-HT is a trophic factor, we hypothesised that maternal diet influences fetal 5-HT exposure, which then influences development of the central appetite network and the subsequent efficacy of 5-HT to control energy balance in later life. Consistent with our hypothesis, pregnant rats fed a low-protein diet exhibited elevated serum levels of 5-HT, which was also evident inthe placenta and fetal brains at embryonic day 16.5. This increase was associated with reduced levels of 5-HT2CR, the primary 5-HT receptor influencing appetite, in the fetal, neonatal and adult hypothalamus. As expected, a reduction of 5-HT2CR was associated with impaired sensitivity to 5-HT-mediated appetite suppression in adulthood. 5-HT primarily achieves effects on appetite by 5-HT2CR stimulation of pro-opiomelanocortin (POMC) peptides within the arcuate nucleus of the hypothalamus (ARC). We show that 5-HT2ARs are also anatomically positioned to influence the activity of ARC POMC neurons and that mRNA encoding 5-HT2AR is increased in the hypothalamus of in utero growth-restricted offspring that underwent rapid postnatal catch-up growth. Furthermore, these animals at 3 months of age are more sensitive to appetite suppression induced by 5-HT2AR agonists. These findings not only reveal a 5-HT-mediated mechanism underlying the programming of susceptibility to obesity, but also provide a promising means to correct it, by treatment with a 5-HT2AR agonist.
| Original language | English |
|---|---|
| Pages (from-to) | 401-412 |
| Number of pages | 12 |
| Journal | DMM Disease Models and Mechanisms |
| Volume | 9 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 1 Apr 2016 |
Bibliographical note
Publisher Copyright:© 2016. Published by The Company of Biologists Ltd.
Funding
This research was supported by the Biotechnology and Biological Sciences Research Council [E007821/1 to M.S.M.-G., R.L.C. and E00797X/1; BB/K001418/1 to L.K.H.]; the British Heart Foundation [FS/09/029/27902 to S.E.O.]; the UK Medical Research Council Metabolic Diseases Unit [MC-UU-12012/4 to S.E.O. and MC-UU-12012/1 to G.S.H.Y.]; the Wellcome Trust [WT081713 and WT098012 to L.K.H.]; the European Union [FP7-HEALTH-266408 Full4Health to G.S.H.Y.]; and the Helmholtz Alliance ICEMED to G.S.H.Y.
| Funders | Funder number |
|---|---|
| Helmholtz Alliance ICEMED | |
| Wellcome Trust | WT098012, WT081713 |
| Seventh Framework Programme | 266408 |
| Medical Research Council | MC_UU_12012/4, MC_UU_12012/1, MC_UU_12012/5 |
| Biotechnology and Biological Sciences Research Council | BB/K001418/1, E00797X/1, E007821/1 |
| British Heart Foundation | FS/09/029/27902 |
| European Commission |
Keywords
- Developmental programming
- Hypothalamus
- Low birth weight
- Maternal diet
- Protein restriction
- Serotonin
